0001600132-18-000025.txt : 20180117
0001600132-18-000025.hdr.sgml : 20180117
20180117165655
ACCESSION NUMBER: 0001600132-18-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180112
FILED AS OF DATE: 20180117
DATE AS OF CHANGE: 20180117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fernandes Peter
CENTRAL INDEX KEY: 0001642618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 18532042
MAIL ADDRESS:
STREET 1: PERRYVILLE III CORPORATE PARK
STREET 2: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
wf-form4_151622620127949.xml
FORM 4
X0306
4
2018-01-12
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001642618
Fernandes Peter
C/O BELLEROPHON THERAPEUTICS, INC.
184 LIBERTY CORNER ROAD, SUITE 302
WARREN
NJ
07059
0
1
0
0
Chief Regulatory & Safety Offr
Common Stock
2018-01-12
4
A
0
31527
0
A
113980
D
Stock Option (right to buy)
2.03
2018-01-12
4
A
0
100000
0
A
2028-01-12
Common Stock
100000.0
100000
D
This option was granted on January 12, 2018. This option vests in quarterly installments over a four-year period from the date of grant.
/s/ Peter Fernandes
2018-01-17